Komori
Presentation materials for financial results4099SHIKOKU KASEI HOLDINGS CORPORATIONMaterials and Chemicals

Supplementary Information on Financial Results for the First Quarter of the Fiscal Year Ending December 2026

In the first quarter of the fiscal year ending December 2026, net sales and profit at every level exceeded the year-earlier period, driven in part by increased sales of fine chemicals, reaching record highs for a first quarter. The full-year net sales forecast was revised upward from ¥8.0 billion to ¥8.8 billion following completion of the acquisition of Timuraya and the incorporation of its plan, while the earnings forecasts were unchanged.

Worth reading
92Important
Scored from 5 of 6 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
3058
¥ million (year-on-year increase in revenue)
Wording
Conditional
How definitive the wording is.

Contents of this document

Supplementary materials to the earnings reportFirst quarter of the fiscal year ending December 202613 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥19,868 million+18.2%
Operating profit¥4,240 million+39.6%
Ordinary income¥4,520 million+60.8%
Net income¥3,041 million+58.0%
Operating profit margin
Rate21.3%
Results for the three months of the current quarter
Net Sales
¥19,868 million
Operating profit
¥4,240 million
Ordinary income
¥4,520 million
Net income
¥3,041 million
Full-year earnings forecast
Net Sales
¥88,000 million
Operating profit
¥14,400 million
Ordinary income
¥14,500 million
Net income
¥10,000 million
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales25% (Chemicals 25%, Building Materials 25%)
Operating profit29% (Chemicals 29%, Building Materials 29%)
Ordinary income31%
Net income31%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Net sales and operating profit in the Chemicals Business are progressing ahead of plan, while net sales and operating profit in the Building Materials Business are progressing below plan. Consolidated Q1 results are progressing ahead of the initial plan.
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • Earnings growth accompanying higher net sales in the Chemicals Business
  • Higher gross margin in the Chemicals Business
  • Earnings growth accompanying higher net sales in the Building Materials Business
  • Higher gross margin in the Building Materials Business
  • Higher raw material prices due to surging aluminum ingot pricesApproximately ¥104 million negative earnings impact
  • Higher logistics costs (Chemicals Business)
  • Higher logistics costs (Building Materials Business)
  • Increase in R&D expenses
  • Human capital investment (wage increases, training and education, etc.)Increase of approximately ¥85 million
  • Increase in other SG&AIncrease of approximately ¥1,203 million
  • Exchange Rate FluctuationsApproximately ¥150 million increase in profit
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Assumed Exchange RatesUSD 1 = ¥150, EUR 1 = ¥175, RMB 1 = ¥21.0
New initiatives
  • Completion of the acquisition of Timuraya and consolidation of its full-year plan
  • Investment to support increased production of GliCAP
  • Introduction of CMS and commitment lines
  • Continued investment in decarbonization, DX and human capital
  • Construction of a new R&D center building
Key KPIsA metric the company considers important as a management benchmark.
  • ROE12.8 %
    Year on year against the same period last year+3.6 percentage points
  • Chemicals business ROIC25.6 %
    Year on year against the same period last yearIncreased from 21.1% at FY2025-end
  • Building Materials business ROIC10.5 %
    Year on year against the same period last yearIncreased from 4.1% at FY2025-end
  • PBR1.89 times
    Year on year against the same period last yearIncreased from 1.25 times at FY2025-end
  • PER15.1 times
    Year on year against the same period last yearIncreased from 14.0 times at FY2025-end
  • Number of meetings with investors145 Engagements
    Year on year against the same period last yearIncreased from 127 meetings in FY2024
Segment results
  • Chemicals Business
    Net Sales146.1 Hundreds of millions of yen (YoY +30.3%)
    Operating profit37.6 Hundreds of millions of yen (YoY +10.5%)
  • Building Materials Business
    Net Sales50 Hundreds of millions of yen (YoY +0.8%)
    Operating profit3.6 Hundreds of millions of yen (YoY +0.9%)
Medium-term management plan targets
Maintain and improve ROE at 10% or above in FY2029. Aim for a level exceeding the 7–8% cost of shareholders' equity.
Financial targets
ROE target10% or higher
Actual ROE12.8%
Actual Chemicals Business ROIC25.6%
Actual Building Materials Business ROIC10.5%
Risk amount incorporated into the outlookThe amount representing the range of variation the company expects in its forecast.
The impact of higher raw material prices, procurement difficulties and logistics disruptions resulting from heightened tensions in the Middle East has not been incorporated into the earnings forecasts because its scope and magnitude are difficult to estimate. Amount: Not disclosed.
Capital expenditures
¥63.8 hundred million plan for the fiscal year ending December 2026
Annual Dividend
Annual¥60 per share
Interim¥30
End of period¥30
Payout ratio
30%. The Company has also disclosed a policy of a 50% total payout ratio and 3% DOE.
Acquisition of treasury shares
Policy of conducting flexible share buybacks. The amount, number of shares and period of the acquisition program are Not disclosed.
Contents of this document
ItemDetails
Document typeSupplementary materials to the earnings report
Fiscal Period CoveredFirst quarter of the fiscal year ending December 2026
Net Sales¥19,868 million (YoY +18.2%)
Operating profit¥4,240 million (YoY +39.6%)
Ordinary income¥4,520 million (YoY +60.8%)
Net income¥3,041 million (YoY +58.0%)
Operating profit marginRate 21.3% / Year-on-year change (points) Not disclosed
Results for the three months of the current quarterNet Sales ¥19,868 million / Operating profit ¥4,240 million / Ordinary income ¥4,520 million / Net income ¥3,041 million
Full-year earnings forecastNet Sales ¥88,000 million / Operating profit ¥14,400 million / Ordinary income ¥14,500 million / Net income ¥10,000 million
Progress against full-year forecastNet Sales 25% (Chemicals 25%, Building Materials 25%) / Operating profit 29% (Chemicals 29%, Building Materials 29%) / Ordinary income 31% / Net income 31%
Self-assessment against the planNet sales and operating profit in the Chemicals Business are progressing ahead of plan, while net sales and operating profit in the Building Materials Business are progressing below plan. Consolidated Q1 results are progressing ahead of the initial plan.
Segment resultsSegment Chemicals Business / Net Sales 146.1 Hundreds of millions of yen (YoY +30.3%) / Operating profit 37.6 Hundreds of millions of yen (YoY +10.5%), Segment Building Materials Business / Net Sales 50 Hundreds of millions of yen (YoY +0.8%) / Operating profit 3.6 Hundreds of millions of yen (YoY +0.9%)
Breakdown of Factors Affecting the ChangeFactors Earnings growth accompanying higher net sales in the Chemicals Business / Amount Not disclosed, Factors Higher gross margin in the Chemicals Business / Amount Not disclosed, Factors Earnings growth accompanying higher net sales in the Building Materials Business / Amount Not disclosed, Factors Higher gross margin in the Building Materials Business / Amount Not disclosed, Factors Higher raw material prices due to surging aluminum ingot prices / Amount Approximately ¥104 million negative earnings impact, Factors Higher logistics costs (Chemicals Business) / Amount Not disclosed, Factors Higher logistics costs (Building Materials Business) / Amount Not disclosed, Factors Increase in R&D expenses / Amount Not disclosed, Factors Human capital investment (wage increases, training and education, etc.) / Amount Increase of approximately ¥85 million, Factors Increase in other SG&A / Amount Increase of approximately ¥1,203 million, Factors Exchange Rate Fluctuations / Amount Approximately ¥150 million increase in profit
Key KPIsIndicator name ROE / Value 12.8 % / Year on year against the same period last year +3.6 percentage points, Indicator name Chemicals business ROIC / Value 25.6 % / Year on year against the same period last year Increased from 21.1% at FY2025-end, Indicator name Building Materials business ROIC / Value 10.5 % / Year on year against the same period last year Increased from 4.1% at FY2025-end, Indicator name PBR / Value 1.89 times / Year on year against the same period last year Increased from 1.25 times at FY2025-end, Indicator name PER / Value 15.1 times / Year on year against the same period last year Increased from 14.0 times at FY2025-end, Indicator name Number of meetings with investors / Value 145 Engagements / Year on year against the same period last year Increased from 127 meetings in FY2024
Assumptions Underlying the Business OutlookAssumed Exchange Rates USD 1 = ¥150, EUR 1 = ¥175, RMB 1 = ¥21.0
Risk amount incorporated into the outlookThe impact of higher raw material prices, procurement difficulties and logistics disruptions resulting from heightened tensions in the Middle East has not been incorporated into the earnings forecasts because its scope and magnitude are difficult to estimate. Amount: Not disclosed.
Medium-term management plan targetsMaintain and improve ROE at 10% or above in FY2029. Aim for a level exceeding the 7–8% cost of shareholders' equity.
Financial targetsROE target 10% or higher / Actual ROE 12.8% / Actual Chemicals Business ROIC 25.6% / Actual Building Materials Business ROIC 10.5%
Annual DividendAnnual ¥60 per share / Interim ¥30 / End of period ¥30
Payout ratio30%. The Company has also disclosed a policy of a 50% total payout ratio and 3% DOE.
Acquisition of treasury sharesPolicy of conducting flexible share buybacks. The amount, number of shares and period of the acquisition program are Not disclosed.
Capital expenditures¥63.8 hundred million (plan for the fiscal year ending December 2026)
New initiativesCompletion of the acquisition of Timuraya and consolidation of its full-year plan, Investment to support increased production of GliCAP, Introduction of CMS and commitment lines, Continued investment in decarbonization, DX and human capital, Construction of a new R&D center building
Items this document does not state (8)
Gross Profit MarginSelling, general and administrative expensesUnit price and quantity metricsNumber of stores and locationsNumber of employeesOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Sales of fine chemicals were strong, increasing net sales and profit in the Chemicals Business. In the Building Materials Business, net sales increased as price increases took hold and through an M&A transaction involving wall materials. The upward revision to the full-year net sales forecast reflects completion of the acquisition of Timuraya and incorporation of its full-year plan.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Supplementary Information on Financial Results for the First Quarter of the Fiscal Year Ending December 2026 | SHIKOKU KASEI HOLDINGS CORPORATION (4099) timely disclosure | Komori